News
-
-
-
-
-
-
-
PRESS RELEASE
EQS-Adhoc: Pentixapharm Holding AG: Pentixapharm outlines new clinical development strategy
Pentixapharm outlines new clinical development strategy focusing on CXCR4 therapeutic and diagnostic oncology programs, discontinuing PTF301 trial in MZL, preparing new trials in hematologic malignancies and Bladder Cancer -
-
PRESS RELEASE
Star Copper Mobilizes 2025 Summer Exploration Targeting Expansion of Existing Discovery
Star Copper Corp. to commence drilling and exploration activities at flagship Star Project in British Columbia's Golden Triangle. Campaign aims to expand known mineralization and test deeper porphyry potential -